Drug Policy Archives - Reason Foundation

Ibogaine offers major promise in treating addiction, mental health

Backgrounder by Madison Carlino and Leonard Gilroy

Optimal framework for the state regulation of hemp cannabinoids

Backgrounder by Michelle Minton and Geoffrey Lawrence

Legalizing psilocybin access in Arizona would benefit mental health

Backgrounder by Leonard Gilroy and Geoffrey Lawrence

Psychedelic treatment for neurodegenerative disorders

Policy Brief by Madison Carlino

Psychedelic drug policy recommendations for the incoming Trump administration

Backgrounder by Geoffrey Lawrence, Leonard Gilroy and Gregory Ferenstein

A framework for federal and state hemp-derived cannabinoid regulation

Policy Brief by Michelle Minton and Geoffrey Lawrence

Getting cannabis legalization right in Hawaii

Policy Brief by Michelle Minton and Geoffrey Lawrence

Ibogaine treatment for opioid use disorder

Policy Brief by Madison Carlino

Regulated psilocybin access in Arizona would help treat mental health conditions

Backgrounder by Leonard Gilroy and Geoffrey Lawrence

A policy framework for personal psychedelics licenses

Policy Brief by Gregory Ferenstein

The implications of federal cannabis rescheduling

Policy Brief by Michelle Minton

The case for interstate marijuana commerce right now

Policy Brief by Geoffrey Lawrence and Michelle Minton

Frequently asked questions about STATES Act 2.0

Backgrounder by Geoffrey Lawrence

Drug Legalization Handbook

Policy Study by Geoffrey Lawrence, Jacob James Rich, Michelle Minton, Veronica Wright, Jeffrey A. Singer, Jeffrey Miron, Erin Partin, Neill Franklin, Michael Galipeau and Howard Woolridge

More Drug Policy